Lakefront Biotherapeutics (LKFT) Tax Rate Growth (1y) (2018 - 2026)
Lakefront Biotherapeutics (LKFT) Tax Rate Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.54 Bn | 1.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.00 |
| Dec 31, 2025 | -431.00 |
| Sep 30, 2025 | -217.00 |
| Jun 30, 2025 | -12.00 |
| Mar 31, 2025 | -364.00 |
| Dec 31, 2024 | -544.00 |
| Sep 30, 2024 | 187.00 |
| Jun 30, 2024 | -9,681.00 |
| Mar 31, 2024 | 410.00 |
| Dec 31, 2023 | 1,092.00 |
| Sep 30, 2023 | -575.00 |
| Jun 30, 2023 | 9,441.00 |
| Mar 31, 2023 | -1,651.00 |
| Dec 31, 2022 | -3,236.00 |
| Sep 30, 2022 | 211.00 |
| Jun 30, 2022 | 5.00 |
| Mar 31, 2022 | 1,330.00 |
| Dec 31, 2021 | 2,568.00 |
| Sep 30, 2021 | -59.00 |
| Jun 30, 2021 | 129.00 |